RetroNectin active Killer cells: Clinical Trials

1 trial of RetroNectin active Killer cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow RetroNectin active Killer cells: new trials by email Literature Review of RetroNectin active Killer cells trials Research Report on RetroNectin active Killer cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
RetroNectin active Killer cells, TAS-102 (trifluridine and tipiracil, Lonsurf®) - Gastric (Stomach) Cancer, Biological Therapy
Phase 2RecruitingChinese PLA General Hospital902025-07-012025-10-08

Conditions studied

Stomach Neoplasms (1)

Sponsors

Chinese PLA General Hospital (1)

Countries

China (1)